Loading...
XJPX4912
Market cap3.10bUSD
Dec 25, Last price  
1,758.00JPY
1D
-0.54%
1Q
11.46%
Jan 2017
-8.31%
Name

Lion Corp

Chart & Performance

D1W1MN
XJPX:4912 chart
P/E
33.23
P/S
1.21
EPS
52.91
Div Yield, %
1.52%
Shrs. gr., 5y
-0.43%
Rev. gr., 5y
2.88%
Revenues
402.77b
+3.31%
309,524,000,000331,483,000,000330,229,000,000341,435,000,000338,383,000,000322,223,000,000331,278,000,000327,516,000,000335,076,000,000352,070,000,000367,475,000,000378,734,000,000395,667,000,000410,535,000,000349,403,000,000347,519,000,000355,352,000,000366,234,000,000389,869,000,000402,767,000,000
Net income
14.62b
-33.34%
-4,723,000,0005,473,000,0005,540,000,0005,423,000,0003,040,000,0005,465,000,0006,041,000,0004,077,000,0004,235,000,0006,097,000,0007,368,000,00010,680,000,00015,951,000,00019,827,000,00025,606,000,00020,559,000,00029,870,000,00023,759,000,00021,939,000,00014,624,000,000
CFO
30.07b
-28.34%
4,270,000,0001,865,000,0003,343,000,00016,030,000,00015,183,000,00024,978,000,00025,518,000,00011,134,000,00018,762,000,00022,910,000,00011,738,000,00035,539,000,00032,269,000,00028,562,000,00031,879,000,00036,762,000,00040,729,000,00019,296,000,00041,962,000,00030,068,000,000
Dividend
Dec 27, 202414 JPY/sh
Earnings
Feb 12, 2025

Profile

Lion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through three segments: Consumer Products Business, Industrial Products Business, and Overseas Business. The company offers dental and oral care products, including toothpastes, toothbrushes, dental floss, dental rinses, mouthwashes and breath fresheners, periodontitis ointments, and denture products; body care products, such as shampoos and conditioners, hand soaps, sanitizers, wet wipes, body washes, skin and acne care products, antiperspirants and deodorants, hair-nourishment treatments, men's care and toiletries products, and foot care products. It also provides antipyretic analgesics, eye drops and eye care products, cold medicines, gargles, cold relief products, topical anti-inflammatory analgesics, antidiarrheal and gastrointestinal medicines, health tonic drinks and vitamin supplements, acne and anti-drowsiness medicines, and dermatologic agents. In addition, the company offers fabric care products, such as laundry detergent, delicate detergent, prewash treatment, stain remover, bleach, and fabric softener; clothing care products; household cleaners; kitchen cleanup products comprises dishwashing detergents and antibacterial and deodorizing products; and food preparation products. Further, it provides health and beauty food products consisting of supplements and health tonic drinks; specialty chemicals, and chemical products, include rubber processing and additive agents, mandrel release agents, fatty acid methyl esters, plant-based electrical insulating oils, concrete admixtures, ground improvement and asphalt recycling agents, surfactants, and cosmetics ingredients, as well as electro-conductive carbon black and pressure-sensitive adhesives; pet supplies; and gift and special order products. The company was founded in 1891 and is headquartered in Tokyo, Japan.
URL
https://www.lion.co.jp/ja/
IPO date
May 16, 1949
Employees
7,587
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
402,767,000
3.31%
389,869,000
6.45%
366,234,000
3.06%
Cost of revenue
382,633,000
377,386,000
346,490,000
Unusual Expense (Income)
NOPBT
20,134,000
12,483,000
19,744,000
NOPBT Margin
5.00%
3.20%
5.39%
Operating Taxes
5,687,000
8,182,000
8,657,000
Tax Rate
28.25%
65.55%
43.85%
NOPAT
14,447,000
4,301,000
11,087,000
Net income
14,624,000
-33.34%
21,939,000
-7.66%
23,759,000
-20.46%
Dividends
(7,385,000)
(6,895,000)
(6,974,000)
Dividend yield
1.98%
1.60%
1.56%
Proceeds from repurchase of equity
(1,000)
(10,001,000)
BB yield
0.00%
2.32%
Debt
Debt current
2,191,000
3,179,000
2,894,000
Long-term debt
58,343,000
59,585,000
12,051,000
Deferred revenue
15,485,000
Other long-term liabilities
10,900,000
16,846,000
1,558,000
Net debt
(67,954,000)
(70,109,000)
(111,055,000)
Cash flow
Cash from operating activities
30,068,000
41,962,000
19,296,000
CAPEX
(23,723,000)
(23,145,000)
(42,921,000)
Cash from investing activities
(34,790,000)
(19,535,000)
(34,177,000)
Cash from financing activities
(11,762,000)
(19,821,000)
(10,225,000)
FCF
(3,996,000)
(31,265,000)
8,250,000
Balance
Cash
85,526,000
109,055,000
103,906,000
Long term investments
42,962,000
23,818,000
22,094,000
Excess cash
108,349,650
113,379,550
107,688,300
Stockholders' equity
274,883,000
256,028,000
234,555,000
Invested Capital
231,024,350
212,620,450
180,272,700
ROIC
6.51%
2.19%
7.29%
ROCE
5.83%
3.80%
6.83%
EV
Common stock shares outstanding
284,813
285,272
291,206
Price
1,308.50
-13.57%
1,514.00
-1.50%
1,537.00
-38.47%
Market cap
372,677,810
-13.71%
431,901,808
-3.50%
447,583,622
-38.45%
EV
322,540,810
376,704,808
349,970,622
EBITDA
40,335,000
30,148,000
33,996,000
EV/EBITDA
8.00
12.50
10.29
Interest
843,000
179,000
136,000
Interest/NOPBT
4.19%
1.43%
0.69%